International Clinical Psychopharmacology

Papers
(The TQCC of International Clinical Psychopharmacology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?40
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia34
The role of personality traits in following quarantine orders during the COVID-19 pandemic20
Antidepressant psychopharmacology: is inflammation a future target?18
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?18
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial16
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?15
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder15
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure14
Clinical specificity profile for novel rapid acting antidepressant drugs14
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge14
Open issues in bipolar and antipsychotic treatments12
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case12
Managing depression in the elderly: real-world clinical considerations and perspectives12
Case series on aripiprazole and dopamine supersensitivity psychosis12
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report11
Debated issues in major psychoses11
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition11
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder10
The Gordian knot of the immune-redox systems’ interactions in psychosis10
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors10
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison10
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia10
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration10
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials10
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder10
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness9
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons9
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?9
Differentiating aspects of oral and long-acting injectable antipsychotic drugs for tailoring the therapy of schizophrenia in clinical practice: a narrative review9
Elevated liver transaminases among patients with psychiatric disorders9
Modulating factors in mood disorders treatment9
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review9
Innovation in psychopharmacology8
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series8
Vitamin E in the treatment of tardive dyskinesia: a meta-analysis8
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results8
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study8
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features7
Case report and systematic review of cerebellar vermis alterations in psychosis7
Allergic reaction induced by subcutaneous administration of ketamine: a case report7
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects7
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study7
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies7
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia7
Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland6
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report6
The challenge of managing difficult to treat psychiatric conditions6
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial6
Interplay of environmental and clinical factors in psychiatric disorders6
Advances in the treatment of depression6
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?6
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience6
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study6
Manic episode in a patient with pancreatic adenocarcinoma: a case report6
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students6
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences6
0.046552181243896